Zurich Cantonal Bank
CMPX icon

Zurich Cantonal Bank’s Compass Therapeutics CMPX Stock Holding History

Zurich Cantonal Bank’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$232K Buy
+43,914
New +$253K ﹤0.01% 2198
2023
Q4 		– Sell
-24,314
Closed -$47.9K – 2747
2023
Q3 		$47.9K Hold
24,314
– – ﹤0.01% 2609
2023
Q2 		$77.3K Buy
+24,314
New +$76.3K ﹤0.01% 2460

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Zurich Cantonal Bank's CMPX Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Compass Therapeutics (CMPX) in Q1 2026: 43,914 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #2198 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in CMPX as recently as Q3 2023.

Zurich Cantonal Bank first reported a position in CMPX in Q2 2023 and has held it in 3 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Zurich Cantonal Bank held 43,914 shares of Compass Therapeutics worth $232K as of Q1 2026.
  • Compass Therapeutics was a new Zurich Cantonal Bank position in Q1 2026.
  • Compass Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2198 holding.
  • Zurich Cantonal Bank first reported a position in Compass Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.